Literature DB >> 16297664

Genotype/phenotype correlations in X-linked agammaglobulinemia.

Arnon Broides1, Wenjian Yang, Mary Ellen Conley.   

Abstract

No clear genotype/phenotype correlations have been established in patients with X-linked agammaglobulinemia (XLA). To determine if the specific mutation in Btk might be one of the factors that influences the severity of disease or if polymorphic variants in Tec, a cytoplasmic tyrosine kinase that might substitute for Btk, could contribute to the clinical phenotype, we examined the age at diagnosis, the percentage of peripheral blood B cells and the plasma IgM in a large group of patients with XLA. The results demonstrated that polymorphic variants in Tec were not correlated with phenotypic markers; however, the specific mutation in Btk did influence disease severity. Mutations that conceivably allow the production of some Btk, amino acid substitutions or splice defects that occur at conserved but not invariant sites in the splice consensus sequence were associated with older age at diagnosis, a higher percentage of B cells in the peripheral circulation and higher concentrations of plasma IgM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297664     DOI: 10.1016/j.clim.2005.10.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  31 in total

1.  Increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia.

Authors:  María Edith González-Serrano; Iris Estrada-García; Dolores Mogica-Martínez; Alejandro González-Garay; Gabriela López-Herrera; Laura Berrón-Ruiz; Sara Elva Espinosa-Padilla; Marco Antonio Yamazaki-Nakashimada; Alexander Vargas-Hernández; Leopoldo Santos-Argumedo; Sergio Antonio Estrada-Parra; Francisco J Espinosa-Rosales
Journal:  J Clin Immunol       Date:  2012-06-05       Impact factor: 8.317

Review 2.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

3.  A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease.

Authors:  M E Conley; D M Farmer; A K Dobbs; V Howard; Y Aiba; S A Shurtleff; T Kurosaki
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

Review 4.  The genetic theory of infectious diseases: a brief history and selected illustrations.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-05-29       Impact factor: 8.929

Review 5.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

Review 6.  Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Authors:  Patrick A Flume; James D Chalmers; Kenneth N Olivier
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

7.  Are patients with X-linked agammaglobulinemia at increased risk of developing acute lymphoblastic leukemia?

Authors:  Mary Ellen Conley
Journal:  J Clin Immunol       Date:  2015-01-29       Impact factor: 8.317

8.  The effects of Bruton tyrosine kinase inhibition on chemotaxis and superoxide generation in human neutrophils.

Authors:  Arnon Broides; Nurit Hadad; Jacov Levy; Rachel Levy
Journal:  J Clin Immunol       Date:  2014-04-26       Impact factor: 8.317

9.  Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia.

Authors:  Pamela P W Lee; Tong-Xin Chen; Li-Ping Jiang; Koon-Wing Chan; Wanling Yang; Bee-Wah Lee; Wen-Chin Chiang; Xiang-Yuan Chen; Susanna F S Fok; Tsz-Leung Lee; Marco H K Ho; Xi-Qiang Yang; Yu-Lung Lau
Journal:  J Clin Immunol       Date:  2009-11-11       Impact factor: 8.317

10.  What does it take to call it a pathogenic mutation?

Authors:  Thomas A Fleisher; Luigi D Notarangelo
Journal:  Clin Immunol       Date:  2008-07-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.